Concepedia

Electropharmacology of Nifekalant, a New Class III Antiarrhythmic Drug

Haruaki Nakaya, Hiroko Uemura

Cardiovascular Drug Reviews · 1998 · 35 citations · 32 references

DOI

Concepts

References

32

Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction

New England Journal of Medicine · 1989 · 3.3K citations

, , +14

Cardiac Electrophysiology: From Cell to Bedside

Annals of Internal Medicine · 1991 · 2.4K citations

, , +14

Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.

Michael C. Sanguinetti, Nancy K. Jurkiewicz · The Journal of General Physiology · 1990 · 1.5K citations · Full text

, , +17

Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

Luc M. Hondeghem, Dirk J. Snyders · Circulation · 1990 · 610 citations · Full text

, , +11

Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide.

Nancy K. Jurkiewicz, Michael C. Sanguinetti · Circulation Research · 1993 · 521 citations · Full text

, , +17